5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Prevention of posterior capsular opacification.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Posterior capsular opacification (PCO) is a common complication of cataract surgery. The development of PCO is due to a combination of the processes of proliferation, migration, and transdifferentiation of residual lens epithelial cells (LECs) on the lens capsule. In the past decades, various forms of PCO prevention have been examined, including adjustments of techniques and intraocular lens materials, pharmacological treatments, and prevention by interfering with biological processes in LECs. The only method so far that seems effective is the implantation of an intraocular lens with sharp edged optics to mechanically prevent PCO formation. In this review, current knowledge of the prevention of PCO will be described. We illustrate the biological pathways underlying PCO formation and the various approaches to interfere with the biological processes to prevent PCO. In this type of prevention, the use of nanotechnological advances can play a role.

          Related collections

          Author and article information

          Journal
          Exp. Eye Res.
          Experimental eye research
          Elsevier BV
          1096-0007
          0014-4835
          Jul 2015
          : 136
          Affiliations
          [1 ] University of Groningen, University Medical Center Groningen, Dept. of Ophthalmology, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Laboratory for Experimental Ophthalmology, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, W.J. Kolff Institute, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands. Electronic address: l.m.nibourg@umcg.nl.
          [2 ] Nano Fiber Matrices B.V., Zernikepark 6-8, 9747 AN Groningen, The Netherlands.
          [3 ] University of Groningen, University Medical Center Groningen, W.J. Kolff Institute, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, Dept. of Biomedical Engineering, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
          [4 ] University of Groningen, University Medical Center Groningen, Dept. of Ophthalmology, Hanzeplein 1, 9713 GZ Groningen, The Netherlands; University of Groningen, University Medical Center Groningen, W.J. Kolff Institute, Antonius Deusinglaan 1, 9713 AV Groningen, The Netherlands.
          Article
          S0014-4835(15)00093-7
          10.1016/j.exer.2015.03.011
          25783492
          ce9666d3-384a-4fd3-be4c-49b129f6267e
          History

          Capsular opacification,Cataract surgery,Epithelial–mesenchymal transition,Nanostructures,Nanotechnology,Prevention

          Comments

          Comment on this article